相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of Infections in the Immunopathogensis of Systemic Sclerosis-Evidence from Serological Studies
Yoav Arnson et al.
CONTEMPORARY CHALLENGES IN AUTOIMMUNITY (2009)
An open-label pilot study of infliximab therapy in diffuse cutaneous systemic sclerosis
C. P. Denton et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Lack of Detection of Agonist Activity by Antibodies to Platelet-Derived Growth Factor Receptor α in a Subset of Normal and Systemic Sclerosis Patient Sera
Nick Loizos et al.
ARTHRITIS AND RHEUMATISM (2009)
Lack of Evidence of Stimulatory Autoantibodies to Platelet-Derived Growth Factor Receptor in Patients With Systemic Sclerosis
Jean-Francois Classen et al.
ARTHRITIS AND RHEUMATISM (2009)
Human Parvovirus B19 (B19V) Infection in Systemic Sclerosis Patients
Krystyna Zakrzewska et al.
INTERVIROLOGY (2009)
Identification of target antigens of antifibroblast antibodies in pulmonary arterial hypertension
Benjamin Terrier et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Anti-PDGFR-α antibodies measured by non-bioactivity assays are not specific for systemic sclerosis
E. Balada et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate
Jaspreet Pannu et al.
ARTHRITIS AND RHEUMATISM (2008)
Is imatinib mesylate a promising drug in systemic sclerosis?
P. L. A. van Daele et al.
ARTHRITIS AND RHEUMATISM (2008)
Systemic sclerosis and infections
Silvia Bellando Randone et al.
AUTOIMMUNITY REVIEWS (2008)
Akt blockade downregulates collagen and upregulates MMP1 in human dermal fibroblasts
Andreea M. Bujor et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
A potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis
Yuval Bibi et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2008)
Successful treatment of resistant scleroderma-associated interstitial lung disease with rituximab
D. McGonagle et al.
RHEUMATOLOGY (2008)
Recombinant human anti-transforming growth factor beta 1 antibody therapy in systemic sclerosis - A multicenter, randomized, placebo-controlled phase I/II trial of CAT-192
Christopher P. Denton et al.
ARTHRITIS AND RHEUMATISM (2007)
Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis
Joerg H. W. Distler et al.
ARTHRITIS AND RHEUMATISM (2007)
Antibodies against human cytomegalovirus in the pathogenesis of systemic sclerosis: A gene array approach
C Lunardi et al.
PLOS MEDICINE (2006)
Understanding and making use of human memory B cells
A Lanzavecchia et al.
IMMUNOLOGICAL REVIEWS (2006)
Scleroderma fibroblasts demonstrate enhanced activation of Akt (protein kinase B) in situ
JB Jun et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus
E Traggiai et al.
NATURE MEDICINE (2004)
Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis
C Chizzolini et al.
ARTHRITIS AND RHEUMATISM (2002)
Systemic sclerosis immunoglobulin G autoantibodies bind the human cytomegalovirus late protein UL94 and induce apoptosis in human endothelial cells
C Lunardi et al.
NATURE MEDICINE (2000)
分享论文
